Skip to main content
Top
Published in: Diabetologia 11/2005

01-11-2005 | Article

Hyperthyroidism impairs pancreatic beta cell adaptations to late pregnancy and maternal liporegulation in the rat

Authors: M. J. Holness, G. K. Greenwood, N. D. Smith, M. C. Sugden

Published in: Diabetologia | Issue 11/2005

Login to get access

Abstract

Aims/hypothesis

Hyperthyroidism modifies lipid dynamics (increased oxidation), impairs insulin action and can suppress insulin secretion. We therefore examined the impact of hyperthyroidism on the relationship between glucose-stimulated insulin secretion (GSIS) and insulin action, using late pregnancy as a model of physiological insulin resistance that is associated with compensatory insulin hypersecretion to maintain glucose tolerance. Our aim was to examine whether hyperthyroidism compromises the regulation of insulin secretion and the ability of insulin to modulate circulating lipid concentrations in late pregnancy.

Materials and methods

Hyperthyroidism was induced by tri-iodothyronine (T3) administration from day 17 to 19 of pregnancy. GSIS was assessed during an IVGTT and during hyperglycaemic clamps in vivo and in vitro, using step-up and -down islet perifusions.

Results

Hyperthyroidism in pregnancy elevated the glucose threshold for GSIS and impaired GSIS at low and high glucose concentrations in islet perifusions. In the intact animal, insulin secretion (after bolus glucose) was more rapidly curtailed following removal of the glucose stimulus to secretion. In contrast, GSIS was maintained during protracted hyperglycaemia (hyperglycaemic clamps) in the hyperthyroid pregnant state in vivo.

Conclusions/interpretation

Hyperthyroidism in vivo during late pregnancy blunts GSIS in subsequently isolated and perifused islets at low and high glucose concentrations. It also adversely affects GSIS under conditions of an acute glucose challenge in vivo. In contrast, GSIS is maintained during sustained hyperglycaemia in vivo, suggesting that in vivo factors can rescue GSIS. The ability of insulin to suppress systemic lipid levels during hyperglycaemic clamps was impaired. We therefore suggest that higher circulating lipids may preserve GSIS under conditions of sustained hyperglycaemia in the hyperthyroid pregnancy.
Literature
1.
go back to reference Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
2.
go back to reference Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed
3.
go back to reference Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35–45CrossRef Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35–45CrossRef
4.
go back to reference Leturque A, Ferre P, Burnol AF, Kande J, Maulard P, Girard J (1986) Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 35:172–177PubMed Leturque A, Ferre P, Burnol AF, Kande J, Maulard P, Girard J (1986) Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 35:172–177PubMed
5.
go back to reference Sugden MC, Greenwood GK, Smith ND, Holness MJ (2003) Peroxisome proliferator-activated receptor-alpha activation during pregnancy attenuates glucose-stimulated insulin hypersecretion in vivo by increasing insulin sensitivity, without impairing pregnancy-induced increases in beta-cell glucose sensing and responsiveness. Endocrinology 144:146–153CrossRefPubMed Sugden MC, Greenwood GK, Smith ND, Holness MJ (2003) Peroxisome proliferator-activated receptor-alpha activation during pregnancy attenuates glucose-stimulated insulin hypersecretion in vivo by increasing insulin sensitivity, without impairing pregnancy-induced increases in beta-cell glucose sensing and responsiveness. Endocrinology 144:146–153CrossRefPubMed
6.
go back to reference Holness MJ, Sugden MC (1997) Glucoregulation during progressive starvation in late pregnancy in the rat. Am J Physiol 272:E556–E561PubMed Holness MJ, Sugden MC (1997) Glucoregulation during progressive starvation in late pregnancy in the rat. Am J Physiol 272:E556–E561PubMed
7.
go back to reference Sugden MC, Holness MJ (1998) Fuel selection: the maternal adaptation to fetal nutrient demand. Biochem Soc Trans 26:79–86PubMed Sugden MC, Holness MJ (1998) Fuel selection: the maternal adaptation to fetal nutrient demand. Biochem Soc Trans 26:79–86PubMed
8.
go back to reference Buchanan TA, Metzger BE, Freinkel N, Bergman RN (1990) Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008–1014PubMed Buchanan TA, Metzger BE, Freinkel N, Bergman RN (1990) Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008–1014PubMed
9.
go back to reference Metzger BE, Bybee DE, Freinkel N, Phelps RL, Radvany RM, Vaisrub N (1985) Gestational diabetes mellitus. Correlations between the phenotypic and genotypic characteristics of the mother and abnormal glucose tolerance during the first year postpartum. Diabetes 34(Suppl 2):111–115PubMed Metzger BE, Bybee DE, Freinkel N, Phelps RL, Radvany RM, Vaisrub N (1985) Gestational diabetes mellitus. Correlations between the phenotypic and genotypic characteristics of the mother and abnormal glucose tolerance during the first year postpartum. Diabetes 34(Suppl 2):111–115PubMed
10.
go back to reference Holness MJ, Sugden MC (1999) Antecedent protein restriction exacerbates development of impaired insulin action after high-fat feeding. Am J Physiol 276:E85–E93PubMed Holness MJ, Sugden MC (1999) Antecedent protein restriction exacerbates development of impaired insulin action after high-fat feeding. Am J Physiol 276:E85–E93PubMed
11.
go back to reference Zammit VA, Waterman IJ, Topping D, McKay G (2001) Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131:2074–2077PubMed Zammit VA, Waterman IJ, Topping D, McKay G (2001) Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131:2074–2077PubMed
12.
go back to reference Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMed Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMed
13.
go back to reference Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176PubMed Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176PubMed
14.
go back to reference Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217PubMed Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217PubMed
15.
go back to reference Charles MA, Eschwege E, Thibult N et al (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40:1101–1106CrossRefPubMed Charles MA, Eschwege E, Thibult N et al (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40:1101–1106CrossRefPubMed
16.
go back to reference Chaves JM, Herrera E (1978) In vitro glycerol metabolism in adipose tissue from fasted pregnant rats. Biochem Biophys Res Commun 85:1299–1306CrossRefPubMed Chaves JM, Herrera E (1978) In vitro glycerol metabolism in adipose tissue from fasted pregnant rats. Biochem Biophys Res Commun 85:1299–1306CrossRefPubMed
17.
go back to reference Knopp RH, Herrera E, Freinkel N (1970) Carbohydrate metabolism in pregnancy: 8. Metabolism of adipose tissue isolated from fed and fasted pregnant rats during late gestation. J Clin Invest 49:1438–1446PubMed Knopp RH, Herrera E, Freinkel N (1970) Carbohydrate metabolism in pregnancy: 8. Metabolism of adipose tissue isolated from fed and fasted pregnant rats during late gestation. J Clin Invest 49:1438–1446PubMed
18.
go back to reference Skryten A, Johnson P, Samsioe G, Gustafson A (1976) Studies in diabetic pregnancy: I. Serum lipids. Acta Obstet Gynecol Scand 55:211–215PubMed Skryten A, Johnson P, Samsioe G, Gustafson A (1976) Studies in diabetic pregnancy: I. Serum lipids. Acta Obstet Gynecol Scand 55:211–215PubMed
19.
go back to reference Martin-Hidalgo A, Holm C, Belfrage P, Schotz MC, Herrera E (1994) Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am J Physiol 266:E930–E935PubMed Martin-Hidalgo A, Holm C, Belfrage P, Schotz MC, Herrera E (1994) Lipoprotein lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am J Physiol 266:E930–E935PubMed
20.
go back to reference Fryer LG, Holness MJ, Sugden MC (1997) Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol 154:513–522CrossRefPubMed Fryer LG, Holness MJ, Sugden MC (1997) Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol 154:513–522CrossRefPubMed
21.
go back to reference Lenzen S, Bailey CJ (1984) Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev 5:411–434PubMed Lenzen S, Bailey CJ (1984) Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev 5:411–434PubMed
22.
go back to reference Becks GP, Burrow GN (1991) Thyroid disease and pregnancy. Med Clin North Am 75:121–150PubMed Becks GP, Burrow GN (1991) Thyroid disease and pregnancy. Med Clin North Am 75:121–150PubMed
23.
go back to reference Riis AL, Gravholt CH, Djurhuus CB et al (2002) Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87:4747–4753CrossRefPubMed Riis AL, Gravholt CH, Djurhuus CB et al (2002) Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87:4747–4753CrossRefPubMed
24.
go back to reference Silvestri E, Moreno M, Lombardi A et al (2005) Thyroid-hormone effects on putative biochemical pathways involved in UCP3 activation in rat skeletal muscle mitochondria. FEBS Lett 579:1639–1645CrossRefPubMed Silvestri E, Moreno M, Lombardi A et al (2005) Thyroid-hormone effects on putative biochemical pathways involved in UCP3 activation in rat skeletal muscle mitochondria. FEBS Lett 579:1639–1645CrossRefPubMed
25.
go back to reference Moller N, Nielsen S, Nyholm B, Porksen N, Alberti KG, Weeke J (1996) Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol (Oxf) 44:453–459CrossRef Moller N, Nielsen S, Nyholm B, Porksen N, Alberti KG, Weeke J (1996) Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol (Oxf) 44:453–459CrossRef
26.
go back to reference Tene C, Zarate A, Basurto L et al (2001) Correction of insulin resistance in methimazole-treated patients with Graves disease. Rev Invest Clin 53:531–535PubMed Tene C, Zarate A, Basurto L et al (2001) Correction of insulin resistance in methimazole-treated patients with Graves disease. Rev Invest Clin 53:531–535PubMed
27.
go back to reference Fukuchi M, Shimabukuro M, Shimajiri Y et al (2002) Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism. Life Sci 71:1059–1070CrossRefPubMed Fukuchi M, Shimabukuro M, Shimajiri Y et al (2002) Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism. Life Sci 71:1059–1070CrossRefPubMed
28.
go back to reference Jorns A, Tiedge M, Lenzen S (2002) Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia 45:851–855CrossRefPubMed Jorns A, Tiedge M, Lenzen S (2002) Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia 45:851–855CrossRefPubMed
29.
go back to reference Sugden MC, Liu YL, Holness MJ (1990) Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat. Biochem J 271:421–425PubMed Sugden MC, Liu YL, Holness MJ (1990) Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat. Biochem J 271:421–425PubMed
30.
go back to reference Thibodeaux JR, Hanson RG, Rogers JM et al (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse: I. Maternal and prenatal evaluations. Toxicol Sci 74:369–381CrossRefPubMed Thibodeaux JR, Hanson RG, Rogers JM et al (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse: I. Maternal and prenatal evaluations. Toxicol Sci 74:369–381CrossRefPubMed
31.
go back to reference Sugden MC, Langdown ML, Harris RA, Holness MJ (2000) Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J 352:731–738CrossRefPubMed Sugden MC, Langdown ML, Harris RA, Holness MJ (2000) Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J 352:731–738CrossRefPubMed
32.
go back to reference Holness MJ (1996) Impact of early growth retardation on glucoregulatory control and insulin action in mature rats. Am J Physiol 270:E946–E954PubMed Holness MJ (1996) Impact of early growth retardation on glucoregulatory control and insulin action in mature rats. Am J Physiol 270:E946–E954PubMed
33.
go back to reference Hughes SJ, Carpinelli A, Niki I, Nicks JL, Ashcroft SJ (1992) Stimulation of insulin release by vasopressin in the clonal beta-cell line, HIT-T15: the role of protein kinase C. J Mol Endocrinol 8:145–153PubMed Hughes SJ, Carpinelli A, Niki I, Nicks JL, Ashcroft SJ (1992) Stimulation of insulin release by vasopressin in the clonal beta-cell line, HIT-T15: the role of protein kinase C. J Mol Endocrinol 8:145–153PubMed
34.
go back to reference Holness MJ, Sugden MC (2001) Dexamethasone during late gestation exacerbates peripheral insulin resistance and selectively targets glucose-sensitive functions in beta cell and liver. Endocrinology 142:3742–3748CrossRefPubMed Holness MJ, Sugden MC (2001) Dexamethasone during late gestation exacerbates peripheral insulin resistance and selectively targets glucose-sensitive functions in beta cell and liver. Endocrinology 142:3742–3748CrossRefPubMed
35.
go back to reference Bliss CR, Wiedenkeller DE, Sharp GW (1990) Maternal diet and insulin secretion in islets of lactating, nonlactating, and young rats. Am J Physiol 259:E568–E575PubMed Bliss CR, Wiedenkeller DE, Sharp GW (1990) Maternal diet and insulin secretion in islets of lactating, nonlactating, and young rats. Am J Physiol 259:E568–E575PubMed
36.
go back to reference Green IC, Taylor KW (1972) Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J Endocrinol 54:317–325PubMed Green IC, Taylor KW (1972) Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J Endocrinol 54:317–325PubMed
37.
go back to reference Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301–307PubMed Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301–307PubMed
38.
go back to reference Wajchenberg BL, Cesar FP, Leme CE, Souza IT, Pieroni RR, Mattar E (1978) Carbohydrate metabolism in thyrotoxicosis: studies on insulin secretion before and after remission from the hyperthyroid state. Horm Metab Res 10:294–299PubMed Wajchenberg BL, Cesar FP, Leme CE, Souza IT, Pieroni RR, Mattar E (1978) Carbohydrate metabolism in thyrotoxicosis: studies on insulin secretion before and after remission from the hyperthyroid state. Horm Metab Res 10:294–299PubMed
39.
go back to reference Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT (1998) Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47:1613–1618PubMed Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT (1998) Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47:1613–1618PubMed
40.
go back to reference Stein DT, Esser V, Stevenson BE et al (1996) Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728–2735PubMed Stein DT, Esser V, Stevenson BE et al (1996) Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728–2735PubMed
41.
go back to reference McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138CrossRefPubMed McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138CrossRefPubMed
42.
go back to reference Roduit R, Nolan C, Alarcon C et al (2004) A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 53:1007–1019PubMed Roduit R, Nolan C, Alarcon C et al (2004) A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 53:1007–1019PubMed
43.
go back to reference Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E (1996) Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats. FEBS Lett 397:260–262CrossRefPubMed Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E (1996) Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats. FEBS Lett 397:260–262CrossRefPubMed
44.
go back to reference Mynatt RL, Park EA, Thorngate FE, Das HK, Cook GA (1994) Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem Biophys Res Commun 201:932–937CrossRefPubMed Mynatt RL, Park EA, Thorngate FE, Das HK, Cook GA (1994) Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem Biophys Res Commun 201:932–937CrossRefPubMed
45.
go back to reference Bech K, Damsbo P, Eldrup E et al (1996) Beta-cell function and glucose and lipid oxidation in Graves’ disease. Clin Endocrinol (Oxf) 44:59–66CrossRef Bech K, Damsbo P, Eldrup E et al (1996) Beta-cell function and glucose and lipid oxidation in Graves’ disease. Clin Endocrinol (Oxf) 44:59–66CrossRef
Metadata
Title
Hyperthyroidism impairs pancreatic beta cell adaptations to late pregnancy and maternal liporegulation in the rat
Authors
M. J. Holness
G. K. Greenwood
N. D. Smith
M. C. Sugden
Publication date
01-11-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1953-6

Other articles of this Issue 11/2005

Diabetologia 11/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.